Non-invasive brain stimulation is rapidly evolving from a research tool to a potential therapeutic intervention. This session explores how different modalities, from electromagnetic to ultrasonic, are refining our ability to causally probe and modulate brain function. By combining mechanistic insights, methodological innovation, and translational ambition, these talks highlight the growing potential of targeted neuromodulation to bridge the gap between basic neuroscience and clinical application.
- 13:00 Prof. Til Ole Bergmann (Johannes Gutenberg University Medical Center, DE) ‘Optimizing target exposure and assessing proof of neural target engagement for TUS in humans’
- 13:45 Prof. Elsa Fouragnan (University of Plymouth, UK) ‘Transcranial Ultrasound Stimulation: From Foundational Findings to Clinical Translation’
- 14:30 TUS safety 'expert consensus and recent events'
- 15:15 END